Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × bemarituzumab × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Tumor-Agnostic 1 Thoracic 1 Genitourinary 1

Conditions

Squamous-Cell Non-Small-Cell Lung Cancer 1

Interventions

Carboplatin 288 Pemetrexed 235 Cisplatin 203 Paclitaxel 169 Erlotinib Hydrochloride 148 pembrolizumab 143 Docetaxel 131 Gemcitabine 104 Nivolumab 98 Bevacizumab 98 Radiotherapy 77 Etoposide 62 durvalumab 54 atezolizumab 44 Ipilimumab 42 Radiosurgery 39 osimertinib 38 Albumin-Bound Paclitaxel 35 130-nm albumin-bound paclitaxel 35 Afatinib 34 Cetuximab 33 Gefitinib 32 Taxes 31 Topotecan 26 Vinorelbine 24 Radiation 23 Drug Therapy 22 Crizotinib 22 Platinum 21 Cyclophosphamide 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05267470 2025-03-25

FORTITUDE-201

Amgen

Phase 1 Terminated

74 enrolled 22 charts

Squamous-Cell Non-Small-Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡